The Energy Balance Study
This study is ongoing, but not recruiting participants.
Sponsor:
University of South Carolina
Information provided by (Responsible Party):
University of South Carolina
ClinicalTrials.gov Identifier:
NCT01746186
First received: November 26, 2012
Last updated: December 18, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study if to determine the specific contributions of energy intake and energy expenditure to changes in body weight and fat.
| Condition |
|---|
|
Total Energy Expenditure,Total Energy Intake |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Further study details as provided by University of South Carolina:
Primary Outcome Measures:
- variation in total energy expenditure and variation in total energy intake contribute to changes in body weight and fat among young adults [ Time Frame: two years ] [ Designated as safety issue: No ]
| Enrollment: | 400 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
21-35 years of age
200 Men and 200 women: Ages 21-27 and Ages 28-35, BMI: 20-35,living in the Columbia, SC area.
|
Detailed Description:
- Changes in body weight and fat will be positively associated with increases in total energy intake.
- Changes in body weight and fat will be positively associated with decreases in total energy expenditure.
Eligibility| Ages Eligible for Study: | 21 Years to 35 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
A total of 400 participants will take part in the Energy Balance Study; 200 men and 200 women from 2 age groups: Ages 21-27 and Ages 28-35. A subsample of 200 will be randomized for doubly labeled water recruitment.
Criteria
Inclusion Criteria:
BMI: 20-35 *Note : For participants that come to Orientation, we are allowing participants with a variance of 0.1 either way in the BMI range: 19.9 - 35.1
- 21-35 years of age
- Men and women
- Email address
- Access to a phone
Exclusion Criteria:
Currently on medications to lose weight
- >90th percentile on the Brief Symptom Inventory (BSI)
- Planning to move from the Greater Columbia area in the next 15 months
- Other medical, psychiatric or behavioral factors that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol.
- Changed birth control status in past 3 months
- Currently taking birth control but plan to stop taking it within the next 12 months or are planning to start taking birth control in the next 12 months
- Planning to have weight loss surgery
- Started or stopped smoking in the past 6 months
- Blood pressure ≥ 150/90
- Blood glucose ≥ 145 mg/dL @ orientation
- Blood glucose ≥ 126 mg/dL @ B3
- Total cholesterol ≥ 240 mg/dl with LDL-C ≥ 190 mg/dl or Triglyceride levels ≥ 300 mg/dL
- Currently diagnosed with or taking medications for a major chronic health condition
- Presence of an eating disorder
- Currently participating in another study
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01746186
Locations
| United States, South Carolina | |
| University of South Carolina | |
| Columbia, South Carolina, United States, 29202 | |
Sponsors and Collaborators
University of South Carolina
Investigators
| Principal Investigator: | Steven Blair, Ph.D | University of South Carolina |
| Principal Investigator: | Greg Hand, Ph.D | University of South Carolina |
More Information
No publications provided
| Responsible Party: | University of South Carolina |
| ClinicalTrials.gov Identifier: | NCT01746186 History of Changes |
| Other Study ID Numbers: | EB2010 |
| Study First Received: | November 26, 2012 |
| Last Updated: | December 18, 2012 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on June 18, 2013